A promising new direction for contrast-enhanced magnetic resonance (MR) imaging involves tracking the migration and biodistribution of superparamagnetic iron oxide (SPIO)-labeled cells in vivo. Despite the large number of cell labeling studies that have been performed with SPIO particles of differing size and surface charge, it remains unclear which SPIO configuration provides optimal contrast in non-phagocytic cells. This is largely because contradictory findings have stemmed from the variability and imprecise control over surface charge, the general need and complexity of transfection and/or targeting agents, and the limited number of particle configurations examined in any given study. In the present study, we systematically evaluated the cellular uptake of SPIO in non-phagocytic T cells over a continuum of particle sizes ranging from 33 nm to nearly 1.5 μm, with precisely controlled surface properties, and without the need for transfection agents. SPIO labeling of T cells was analyzed by flow cytometry and contrast enhancement was determined by relaxometry. SPIO uptake was dose-dependent and exhibited sigmoidal charge dependence, which was shown to saturate at different levels of functionalization. Efficient labeling of cells was observed for particles up to 300 nm, however, micron-sized particle uptake was limited. Our results show that an unconventional highly cationic particle configuration at 107 nm maximized MR contrast of T cells, outperforming the widely utilized USPIO (<50 >nm). Despite the large number of cell labeling studies that have been performed with SPIO particles of differing size and surface charge, it remains unclear in which SPIO configuration provides optimal contrast in nonphagocytic cells. This is largely because contradictory findings have stemmed from the variability and imprecise control over surface charge, the general need and complexity of transfection and/or targeting agents, and the limited number of particle configurations examined in any given study. In the present study, we systematically evaluated the cellular uptake of SPIO in non-phagocytic T cells over a continuum of particle sizes ranging from 33 nm to nearly 1.5 mm, with precisely controlled surface properties, and without the need for transfection agents. SPIO labeling of T cells was analyzed by flow cytometry and contrast enhancement was determined by relaxometry. SPIO uptake was dose-dependent and exhibited sigmoidal charge dependence, which was shown to saturate at different levels of functionalization. Efficient labeling of cells was observed for particles up to 300 nm, however, micron-sized particle uptake was limited. Our results show that an unconventional highly cationic particle configuration at 107 nm maximized MR contrast of T cells, outperforming the widely utilized USPIO (<50 nm).
Introduction
Continuing advancements in cell-based therapies have recently led to the emergence of cellular imaging as a strategy to track the migration and biodistribution of target cells in living organisms. Pre-clinical studies have already shown that cellular imaging can be used to evaluate stem cell distribution and homing in cell-based regenerative therapies [1, 2] . Recently, cellular imaging has also allowed for improved assessment of functional efficacy and applicability of immunotherapeutic treatments in disease models for cancer [3] [4] [5] and AIDS [6] .
In addition to evaluating cell-based therapies, cellular imaging also promises to provide a great deal of insight into diverse physioand pathological phenomena. Interesting applications include the observation of monocyte recruitment to atherosclerotic lesions for the mapping of disease development and therapeutic intervention [7] , imaging embryonic stem cell movement during embryonic [8] and organ development [9] and monitoring the dynamics of metastatic cellular extravasation and tissue invasion [10, 11] .
Tracking of labeled cells has been accomplished with a variety of imaging modalities including optical methods, positron emission tomography (PET), single photon emission computed tomography (SPECT), and magnetic resonance (MR) imaging [12] [13] [14] . MR imaging presents a particularly promising approach because of its high spatial resolution in three dimensions and exquisite soft tissue contrast, which can be acquired concomitantly with the contrastenhanced cellular distribution. MR detection of cells in vivo is often accomplished following labeling with superparamagnetic iron oxide (SPIO) particles. SPIO is negative contrast agents that are typically composed of an iron oxide crystal core surrounded by a polymer or polysaccharide shell [15] . A variety of manifestations of SPIO have been used to track cells, which can be broadly categorized as (1) ultrasmall SPIO (USPIO) with an overall diameter of 30-50 nm [16] , (2) standard SPIO (SSPIO) with a diameter of 50-150 nm and (3) micron-sized paramagnetic iron oxide (MPIO) having a diameter approaching or greater than 1 mm [17] .
To date, USPIO has perhaps been the most widely utilized SPIO configuration for cell labeling. Although they provide less contrast enhancement per particle compared with SSPIO and MPIO, large numbers of particles can be loaded into each cell [18, 19] . As cationic surfaces have been shown to facilitate cellular internalization [20, 21] , USPIO is often modified with polycationic cell permeating peptides (CPPs) such as HIV transactivator (TAT) [22] or protamine [23] . Other transfection techniques, sometimes in concert with CPPs, are also used [24, 25] .
U N C O R R E C T E D P R O O F
An exciting new direction for cell tracking involves labeling cells with MPIO [26] . The large iron oxide cores present in these particles provide enough contrast for single cells to be imaged by MR. However, work with such large particles generally confines application of iron oxide labeling to phenotypes such as macrophages [18] , dendritic cells [27] or hepatocytes that actively internalize foreign material. MPIO uptake in non-phagocytic cells has been accomplished, but is limited by the additional conjugation work and cost of using an antibody-mediated approach [28] , which must be species specific and may induce adverse cellular events.
Recently, several studies have attempted to define an optimized particle configuration for iron oxide labeling of both phagocytic and non-phagocytic cell types. Although MPIO was excluded from all of these studies, it was found that phagocytic monocytes are more effectively labeled with SSPIO (150 nm) compared with USPIO (30 nm) [18, 29] . Further, it was found that ionic carboxydextrancoated SSPIO (i.e. ferucarbotran) performed better than non-ionic dextran-coated SSPIO (i.e. ferumoxide) [18] . It remains unclear how MPIO compares with these agents; however, single cell detection has been achieved in phagocytic cells with both SPIO configurations [30, 31] .
The optimal SPIO configuration for labeling non-phagocytic cells has been much more elusive and findings have been contradictory. For example, in one study it was found that the delivery of carboxydextran USPIO and dextran-labeled SSPIO into non-phagocytic cancer cells and leukocytes (with the assistance of lipofection agents) was similar in terms of iron uptake [21] . Both particles led to higher iron uptake than USPIO. This indirectly suggests that larger particles with ionic coatings are superior to non-ionic USPIO. However, in a different study it was found that, in the presence of poly-L-lysine, ion Q2 ic (aminated) USPIO exhibited significantly higher iron uptake in non-phagocytic cells compared with SSPIO. These data suggest that smaller ionic particles are internalized into nonphagocytic cells more efficiently [32] . These contradictory findings likely stem from the variability and imprecise control over surface charge and the limited number of particle configurations examined, particularly with respect to diameter (ranging only from w17 nm to 150 nm).
In the present study we systematically evaluated the cellular uptake of SPIO in non-phagocytic T cells over a continuum of particle sizes ranging from 33 nm to nearly 1.5 mm and with precisely controlled surface properties. T cells were selected as a model nonphagocytic phenotype since visualization of their distribution is expected to be of importance for adoptive T cell therapy for cancer and T cell homing in autoimmune diseases. Extremely fine control was exerted on the surface properties of SPIO by direct chemical modification of particle surfaces rather than attempting to modulate the density of supplemental transfection agents. Concentration effects and incubation times were also tested in the interest of isolating the role particle size exerts on individual cell uptake and overall contrast enhancement. Our work shows that in a space between USPIO and MPIO exist configurations of relatively small particles (w100 nm) that efficiently label non-adherent, nonphagocytic T cells and generate higher relaxivity (per cell) relative to particles of other sizes.
Materials and methods

Nanoparticle synthesis
Three different formulations of dextran-coated superparamagnetic iron oxide nanoparticles were prepared using the co-precipitation method [33] . All three formulations were prepared following the same procedure, as described below, with the only difference being the amount of FeCl 2 and FeCl 3 added. Specifically, 25 g of dextran T10 (GE Healthcare, Piscataway, NJ) was dissolved in 50 mL of dH 2 O and heated to 80 C for 1 h. The solution was allowed to return to room temperature and continued to mix overnight. Subsequently, the dextran was cooled to 4 C on ice and degassed with N 2 for 1 h. FeCl 2 (0.7313 g, 1.5 g, or 2.2 g) and FeCl 3 (1.97 g, 4 g, or 6 g, respectively) were each rapidly dissolved in 12.5 mL of degassed dH 2 O and kept on ice for approximately 10 min. The iron solutions were added to the dextran simultaneously and allowed to mix for 30 min. Keeping this mixing solution at 4 C, 15 mL of ammonium hydroxide was added. The resulting black viscous solution was then heated to 90 C for 1 h then cooled overnight, followed by ultracentrifugation at 20 k rcf for 30 min. Pellets were discarded and the supernatant was continually diafiltrated using a 100-kDa MWCO cartridge (GE Healthcare) on a peristaltic pump (E323, Watson Marlow Bredel, Wilmingt Q3 on, MA). The particles were exchanged into 0.02 M citrate, 0.15 M sodium chloride buffer until all unreacted products had been removed. Aminated silica-coated iron oxide micro-particles were purchased from Bioclone Inc. (San Diego, CA). Amine functionalized styrene copolymer-coated iron oxide particles (Adembeads) were purchased from Ademtech SA (Pessac, France).
Amination of particles
Amination and crosslinking of the coating on the dextran-SPIO were accomplished through reaction of the SPIO with 25% 10 M NaOH and 33% epichlorohydrin [34] . After mixing for 24 h, additional ammonium hydroxide was added to the solution, bringing the volume fraction to 25% ammonium hydroxide, and the reaction was allowed to proceed for another 24 h. The particles were then exhaustively purified via diafiltration. The resulting particles were amine functionalized crosslinked iron oxide.
FITC labeling and amine-blocking of particles
All SPIO particles were labeled with FITC at a FITC-to-iron molar ratio of 19.2:1. FITC was reacted with particles for 4 h followed by two rounds of gel purification, once on a NAP-5 column and then on a PD10 column (GE Healthcare), both equilibrated with PBS. The FITC-labeled SPIO was subsequently reacted with various volumes of glycidol (0.01-50%) to produce populations of particles with different amine content. The particles were cleaned off excess glycidol through repeated precipitation in isopropanol and resuspension in PBS. Amine-blocking was also attempted with particles of 200 nm and greater, but this modification impelled immediate particle insolubility.
Measurement of particle size
The hydrodynamic diameter of the dextran-coated and commercial iron oxide particles was measured using a Zetasizer Nano-z (Malvern Instruments, Malvern, UK) through dynamic light scattering (DLS). The dextran-coated SPIO particles were diluted in PBS to a concentration of approximately 0.5 mg/mL and read in triplicate. The commercial particle diameters were read in the same manner, but only after undergoing three washes by precipitation in the presence of a strong magnet and resuspension in PBS. The values reported for all samples are the intensity peak values.
Measurement of particle cores
Transmission electron micrographs of all iron oxide particles were taken using a JEOL 2010 at 200 kV. Samples were prepared for imaging by evaporating the particles onto a carbon-coated copper grid (Holey carbon -mesh 200, Structure Probe Inc., West Chester, PA). Salt was removed from all of the samples prior to evaporation by exchanging the particles into dH 2 O. Images of particle cores were analyzed using ImageJ (National Institutes of Health, Bethesda, MD). Since many of the particles were found to be composed of a cluster of multiple iron oxide cores, the average diameter of each core and the average number of cores per particle were determined. Assuming each core to be spherical, the amount of iron per particle type was determined from the aggregate core volume.
Measurement of particle relaxivity (R 1 and R 2 )
The longitudinal (R 1 ) and transverse (R 2 ) relaxivity of each particle was calculated as the slope of the curves 1/T 1 and 1/T 2 against iron concentration, respectively. T 1 and T 2 relaxation times were determined using a Bruker mq60 MR relaxometer operating at 1.41 T (60 MHz). T 1 measurements were performed by collecting 12 data points from 5.0 ms to 1000 ms with a total measurement duration of 1.49 min.
T 2 measurements were made using s ¼ 1.5 ms and two dummy echoes, and fitted assuming monoexponential decay.
Measurement of number of amines per particle
The number of amines per particle was determined following the general procedure described by Zhao et al. [35] . Briefly, iron oxide particles at a concentration of 2 mg/mL Fe were reacted with excess N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP, Calbiochem, San Diego, CA) for 4 h. SPIO was washed off excess SPDP through repeated precipitation in isopropanol and resuspension in PBS. The particles were then run through a 50-kDa MWCO centrifugal filter (YM-50, Millipore, Billerica, MA) either with or without the addition of disulfide cleavage agent TCEP. The difference of the absorbance of these two samples at 343 nm was used to determine the 110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175   176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204  205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240 241
concentration of SPDP in the filter flow. Adjusting for dilution, the number of amines per particle was determined.
Cell culture and labeling
Immortalized human T cells, Jurkat Clone E6-1 (ATCC), were maintained at 37 C in 5% CO 2 in RPMI 1640 (Mediatech, Manassas, VA) media supplemented with 10% FBS (Hyclone, Logan, UT) and penicillin/streptomycin (Mediatech). T cells were labeled with iron oxide particles by incubating the commercial and lab-made particles with 2 Â 10 6 cells in 400 mL of fully supplemented media for 1 h or 4 h, at 37 C in 5% CO 2 . Cells were washed off non-internalized particles through two methods. Synthesized dextran-coated particles were washed from cells using centrifugation. Specifically, cells were pelleted at 0.5 rcf for 5 min and resuspended in PBS. This was repeated three times. The dextran-coated particles are highly soluble in aqueous solvents and do not precipitate at these centrifugation speeds. Removal of noninternalized commercial particles was accomplished through a density gradient. The cells and particles were diluted to 1 mL with PBS and overlayed on 4 mL of room temperature Ficoll-Paque PLUS (GE Healthcare). The sample was centrifuged at 0.4 rcf for 40 min. Cells loaded with particles were retrieved from the interface layer. To determine if particles were internalized or merely adsorbed on the cell exterior, surface receptor cleavage enzyme trypsin was used. Following particle incubation, as described above, cells were exposed to 0.025% trypsin-EDTA (Invitrogen) for 5 min. Purification of non-internalized particles was carried out as detailed. No statistical difference was seen in either flow cytometry or relaxometry between groups washed with or without enzyme.
Flow cytometry and relaxation measurements
Immediately after non-internalized iron oxide particles were removed from T cell samples, flow cytometry was performed on a Guava Easycyte (Guava Technologies, Hayward, CA). For labeling and viability experiments, forward and side scatterings were used to identify the entire population of cells. Data analysis of flow cytometry data was accomplished with FlowJo (TreeStar, Ashland, OR). Viability of T cells was determined using the LIVE/DEAD cytotoxicity kit for mammalian cells (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. In order to evaluate the decrease in T 2 relaxation time of iron oxide internalized T cells, purified cells were lysed for 30 min in 0.1% SDS in PBS at 37 C. Samples were diluted to 0.5 Â 10 6 cells/mL in 300 uL and T 2 relaxation times were measured using the benchtop relaxometer. All flow and magnetic resonance measurements were made in triplicate on at least two separate occasions.
Results and discussion
Particle synthesis and characterization
Three different formulations of dextran-coated superparamagnetic iron oxide nanoparticles were prepared via co-precipitation. All three syntheses utilized a ratio of approximately three ferrous to ferric iron chloride; however, the total amount of iron was increased by whole numbers, i.e. 2Â and 3Â irons, respectively. This deviation in the amount of iron present during synthesis allowed for the manufacture of SPIO with a range of different sizes and properties. Specifically, DLS of the SPIO, following crosslinking and amination of the dextran coating, indicated average hydrodynamic radii of 33.4 nm, 53.5 nm and 107 nm, respectively, with the larger nanoparticles corresponding to syntheses that utilized more iron. When the total amount of iron was increased further, the co-precipitation solution became extremely viscous and yielded highly dispersed aggregates that precipitated out of solution. Therefore, nanoparticles ranging from 200 nm to 1 mm in diameter were acquired from commercial sources. Specifically, superparamagnetic iron oxide particles of 200 nm and 300 nm diameter with an amine functionalized styrene copolymer coating (Amino-Adembeads) were purchased from Ademtech, while amine functionalized silica-coated 1 mm diameter particles were purchased from Bioclone. This allowed particle sizes across nearly three orders of magnitude to be compared.
The particle sizes as determined by DLS, peak intensity values, are compared in Fig. 1 . The 33.4 nm, 53.5 nm and 107 nm dextrancoated SPIO samples were fully soluble at physiological conditions. Conversely, it was found that the large size of the 289 nm and 1430 nm particles led to rapid precipitation. Settling was also a concern for the 207 nm particles; however, full precipitation generally took several hours.
Analysis of the iron oxide core size and structure of the magnetic particles was conducted using TEM. Representative micrographs are shown in Fig. 2 . Aggregation of particles in salt free solution was a problem during TEM sample preparation; however, reduction in sample concentration allowed for imaging of discretely distributed particles. Iron cores were easily distinguished from carbon-coated copper grids, while dextran and styrene copolymer were not visible because of their low electron density.
An interesting feature of the dextran-coated nanoparticles is that each particle consists of a cluster of one or more iron oxide cores, with each core being approximately equal in size. Specifically, the distribution of cores is centered at approximately 6 nm for all three dextran-coated nanoparticles (Fig. 3) ; however, the average number of cores per particle increases with overall hydrodynamic diameter. In contrast, the larger 207 nm and 289 nm styrene copolymer-coated particles exhibited a single large spherical iron oxide core, while the 1.43 mm silica-coated particles exhibited an amorphous iron oxide core of no discrete size or shape. A summary of the properties of each SPIO is provided in Table 1 .
The R 1 and R 2 data (Figs. 4 and 5), also summarized in Table 1 , indicate that there is a trend of increasing R 2 and decreasing R 1 with size up to the 107 nm particles. For particles of greater size, the single large core of the 207 nm and 289 nm particles does not translate into proportionately higher R 2 . This likely reflects lower crystallinity of the larger single iron oxide cores in comparison to smaller crystals [36] . Furthermore, according to the SolomonBloembergen theory, which relates the relaxation rate to particle properties, the total size of the particle is not critical to the magnitude of R 2 as the susceptibility effect falls off from the surface with an exponential (r 6 ) dependence [37, 38] . It should be noted that the R 1 values reported for particles greater than 200 nm are likely underestimates due to precipitation of the particles during T 1 measurements. For instance, determining T 1 relaxation times required more than 100 s per sample, which was an ample time for the micrometer-sized particles to precipitate out of solution.
Cell loading
The extent to which T cells internalize iron oxide particles is not only dependent on particle size but also various other particle characteristics and cell loading conditions, including surface charge, particle concentration, and incubation time. Thus, before it 242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307   308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373 U N C O R R E C T E D P R O O F could be determined which particle size led to the highest relaxivity per cell, it was first necessary to identify conditions whereby cell loading was independent of these other parameters. The use of fluorescently labeled iron oxide particles combined with flow cytometry provided a facile method by which particle uptake could be systematically assessed in a high-throughput manner. In the current study, all SPIO samples were fluorescently labeled with an equivalent amount of FITC/iron.
Concentrati
Q4
on In order to confirm that iron oxide particles were present in sufficient quantity for maximum cellular uptake, T cells were incubated with increasing iron concentrations until a saturating level was reached. As shown in Fig. 6 , dextran-coated particles were efficiently internalized, all reaching a plateau at iron concentrations below 50 mg/mL. Greater than 100 mg/mL was required to saturate the loading of the 207 nm, 289 nm and 1430 nm particles. The necessity for these higher iron concentrations may be attributed to the fact that the number of particles per unit of iron is far less than the smaller agents. Further, there is likely less contact between the larger particles and the suspended cells because of their continual sedimentation. This was perhaps most evident with MPIO, where cell labeling was poor across all particle concentrations. Even at 1000 mg/mL (data not shown) labeling with MPIO did not reach the levels achieved by the dextran-coated USPIO and SPIO.
Surface properties
Surface charge is important for intracellular delivery of exogenous material. This principle has been described for a variety of nanoparticle (examples include gold [39] , polymer [40, 41] and silica [42] ) and biological (for example, delivery of DNA with cationic proteins, lipids and polymers [43] ) contexts. The aminated surfaces of the particles used in this study provide an inherent surface charge, facilitating cellular interaction. However, in order to study the role this property has in the intracellular delivery of iron oxide contrast agent, it is necessary to manipulate the magnitude of the surface charge. To do so we have applied glycidol, a hydroxyl terminating epoxide, to generate subsets of particles with a gradient of surface amines. Glycidol has been used previously in dendrimer chemistry to reduce the chemotoxicity of highly-positively charged dendrimers [44] . The tight control of surface properties produced by consuming amines with glycidol allows for isolated examination and evaluation of the role of surface charge on SPIO.
The summary of particle uptake on a per cell basis is shown in Fig. 7(A-C) . Each data point represents the normalized mean fluorescence intensity (MFI) of T cells that were incubated with iron oxide particles at a saturating concentration (previously determined) for 4 h. Under these incubation conditions, it was found that particles in their natural (fully aminated) state are maximally internalized. Any further increase in the positive surface charge will not further augment SPIO loading. In other words, the efficiency of cell labeling has become independent of surface charge. In all cases, uptake and internalization of the particles were rapid. Representative uptake of the 107 nm particles as a function of time is shown in Fig. 7(D) .
Viability
The impact and potential cytotoxicity of each iron oxide particle on T cells were measured using a two-color fluorescent cell viability kit. Negligible to low levels of cell death were observed (Fig. 8) for all particles at diminished and saturating concentrations of iron oxide (10 mg/mL and 50 mg/mL, respectively). The exception was for 
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the 107 nm SPIO, which exhibited some adverse cell influence even at 10 mg/mL. This effect was exacerbated at increased concentrations. When the amines on the 107 nm particle were completely blocked, cell death was reduced to negligible levels; however, internalization was also reduced to negligible levels (Fig. 7C) . T cell death is likely attributable to the high positive surface charge possessed by the SPIO. Similar results have been seen with amineterminated poly(amidoamine) dendrimers [45] . The extremely high driving force for cell internalization imparted by positive SPIO surface charge can lead to cell death.
In order to minimize the toxicity of the 107 nm particles, the incubation time with T cells was decreased to 1 h. As shown in Fig. 7D , particle uptake is still saturated within this time frame, therefore exposing T cells to excess SPIO for longer periods of time was deemed unnecessary. No toxicity was observed with the 107 nm particles after just 1 h of incubation.
Magnetic contrast enhancement
Flow cytometry was utilized to determine the saturating conditions for each SPIO; however, these single cell measurements were conducted with some variation between the number of fluorescent labels per particle making it difficult to accurately quantify the number of particles per cell. Also, after labeling cells with superparamagnetic tracking agents the critical assessment of ability to track cells is their relaxivity. Therefore, a benchtop NMR minispectrometer, near the clinical field strength of 1.5 T, was utilized for evaluating in vitro loading. As shown in Fig. 9 , T cells loaded with particles showed a dose-dependent, negative contrast enhancement.
As befits their widespread application in the literature, the USPIO proved effective at lowering the spin-spin relaxation time (T 2 ). Despite delivering only a small payload of iron per particle, the large numbers of 33.4 nm and 53.5 nm particles that accumulate in The cores diameters were analyzed assuming that they were spherical and the frequency and cumulative distributions are plotted. Particle size appears to be determined by the number of cores per particle rather than the size of those constituent cores. 506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571   572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594  595  596  597  598  599  600  601  602  603  604  605  606  607  608  609  610  611  612  613  614  615  616  617  618  619  620  621  622  623  624  625  626  627  628  629  630  631  632  633  634  635  636 Performance of particles greater than 200 nm was ranked inversely with diameter. Greater concentrations of large particles continued to reduce the T 2 signal; however, when the iron concentration was increased above 500 mg/mL the methods used to distinctly separate loaded-cells from free particles became less reliable. It should be noted that this drawback does not exist for the flow cytometry measurements, as the particles themselves could be excluded from the cells based on forward and side scatter. At 150 mg/mL Fe, the spin-spin relaxation signal from the 207 nm, Fig. 6 . Dependence of SPIO loading on particle concentration. Fluorescently labeled SPIO of various sizes and across a range of concentrations was incubated with 2 Â 10 6 T cells/mL at 37 C for 4 h (excluding the 107 nm particle as indicated). SPIO uptake was then measured by flow cytometry. Each experiment was conducted in triplicate on at least two separate occasions and each data point represents the average value for the mean fluorescent intensity (MFI). Note the difference in x-and y-axes for (A) and (B). The highly-aminated SPIO with a diameter of 107 nm produced the greatest contrast enhancement. These particles combined the high degree of internalization of the USPIO with the superior relaxivity of larger particles. At the 1 h loading time, to avoid any longer term cytotoxic events, these SSPIO were able to reduce signal approximately two orders of magnitude, providing T 2 signal of only 12.25 ms, or an 82.74 times reduction in signal from control. This reduction in signal was approximately five and 10 times greater than that produced by the 53.5 nm and 33.4 nm SPIO (for the same concentration). After 4 h (unless otherwise noted), viability was measured and normalized to cells grown in the absence of any particles (blank). All SPIO exhibited negligible impact on cell survival after 4 h, excluding the 107 nm diameter particles. Reducing incubation time of these particles to 1 h eliminated adverse effects at both low and saturating concentrations. 
